
Genmab Investor Relations Material
Genmab, a biotechnology company, develops antibody therapeutics for the treatment of cancer and other diseases primarily in Europe.
Upcoming events for
Q2 20222022-08-10
Latest company events
More about Genmab
Ticker symbol
GMAB
Country
Denmark